Sign in

CIK 0002100782 · <br>Emerging growth company

Generate Biomedicines, Inc.

Sign in to watch
Ticker
GENB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
831630228
Phone
888-469-0055
Business address
101 SOUTH STREET, SUITE 900, SOMERVILLE, MA, 02143
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$200,735
in 2 filings, $201K under 10b5-1 plans

Net −$200,735. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ARNOLD FRANCES −$201K Director sold 5% of stake
Date Insider Transaction Shares Price Value Owned after
2026-03-02 AFEYAN NOUBAR Director Conversion · Series A Preferred Stock −1,500,000 0
2026-03-02 AFEYAN NOUBAR Director Conversion · Series B Preferred Stock −843,881 0
2026-03-02 AFEYAN NOUBAR Director Conversion · Series B Preferred Stock −1,265,822 0
2026-03-02 AFEYAN NOUBAR Director Conversion · Series B Preferred Stock −2,953,586 0
2026-03-02 AFEYAN NOUBAR Director Conversion · Series B Preferred Stock −2,109,704 0
2026-03-02 AFEYAN NOUBAR Director Conversion · Series C Preferred Stock −2,531,644 0
2026-03-02 AFEYAN NOUBAR Director Conversion · Series C Preferred Stock −1,265,822 0
2026-03-02 AFEYAN NOUBAR Director Conversion · Series C Preferred Stock −2,109,704 0
2026-02-26 Vessey Rupert Director Grant or award · Stock Option (Right to Buy) +29,561 29,561
2026-02-26 Grous Beth Chief People Officer Grant or award · Stock Option (Right to Buy) +114,020 114,020
2026-02-26 ARNOLD FRANCES Director Grant or award · Stock Option (Right to Buy) +29,561 29,561
2026-02-26 Lee Laurie Anne Chief Medical Officer Grant or award · Stock Option (Right to Buy) +42,230 42,230
2026-02-26 Martin Sean Chief Legal Officer & GC Grant or award · Stock Option (Right to Buy) +190,034 190,034
2026-02-26 Simonian Nancy A Director Grant or award · Stock Option (Right to Buy) +29,561 29,561
2026-02-26 Silvers Jason President & CFO Grant or award · Stock Option (Right to Buy) +295,608 295,608
2026-02-26 Silvers Jason President & CFO Grant or award · Stock Option (Right to Buy) +274,493 274,493
2026-02-26 AFEYAN NOUBAR Director Grant or award · Stock Option (Right to Buy) +29,561 29,561
2026-02-26 Grigoryan Gevorg Chief Technology Officer Grant or award · Stock Option (Right to Buy) +295,608 295,608
2026-02-26 Grigoryan Gevorg Chief Technology Officer Grant or award · Stock Option (Right to Buy) +196,368 196,368
2026-02-26 Nally Michael Chief Executive Officer Grant or award · Stock Option (Right to Buy) +844,595 844,595

Page 3 of 4 · 66 trades